Whitehawk Therapeutics, Inc. (WHWK)
NASDAQ: WHWK · Real-Time Price · USD
4.080
+0.330 (8.80%)
At close: Mar 9, 2026, 4:00 PM EDT
4.070
-0.010 (-0.25%)
After-hours: Mar 9, 2026, 7:07 PM EDT
Whitehawk Therapeutics Employees
Whitehawk Therapeutics had 40 employees as of December 31, 2024. The number of employees decreased by 49 or -55.06% compared to the previous year.
Employees
40
Change (1Y)
-49
Growth (1Y)
-55.06%
Revenue / Employee
$653,818
Profits / Employee
-$709,909
Market Cap
192.28M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 40 | -49 | -55.06% |
| Dec 31, 2023 | 89 | 10 | 12.66% |
| Dec 31, 2022 | 79 | 40 | 102.56% |
| Dec 31, 2021 | 39 | 31 | 387.50% |
| Dec 31, 2020 | 8 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Molecular Partners AG | 153 |
| Caribou Biosciences | 147 |
| Heron Therapeutics | 128 |
| Vaxart | 105 |
| Nkarta | 105 |
| Tonix Pharmaceuticals Holding | 81 |
| Cartesian Therapeutics | 66 |
| SAB Biotherapeutics | 63 |
WHWK News
- 11 days ago - Whitehawk Therapeutics to Participate in Upcoming Investor Conferences - PRNewsWire
- 19 days ago - Whitehawk Therapeutics to Present at the Oppenheimer 36th Annual Healthcare Life Sciences Conference - PRNewsWire
- 2 months ago - Whitehawk Therapeutics Advances to Clinical Stage with IND Clearance for HWK-007 and Announces IND Submission for HWK-016 - PRNewsWire
- 3 months ago - Whitehawk Therapeutics Appoints Margaret Dugan, MD, as Chief Medical Officer - PRNewsWire
- 3 months ago - Whitehawk Therapeutics to Participate in the Piper Sandler 37th Annual Healthcare Conference - PRNewsWire
- 4 months ago - Whitehawk Therapeutics to Present at Jefferies Global Healthcare Conference in London - PRNewsWire
- 4 months ago - Whitehawk Therapeutics Reports Third Quarter 2025 Financial Results and Recent Highlights - PRNewsWire
- 4 months ago - Whitehawk Therapeutics Presents Real-World Analysis Confirming PTK7 as a Broadly Expressed, Clinically Relevant Target Across Solid Tumors at AACR-NCI-EORTC - PRNewsWire